C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma

Clinical Nuclear Medicine

Volumn 34, Issue 10, 2009, Pages 659-665

  Magini, Giulia ^a   Farsad, Mohsen ^a   Frigerio, Marta ^a   Serra, Carla ^a   Colecchia, Antonio ^a   Jovine, Elio ^b   Vivarelli, Marco ^a   Feletti, Valentina ^a   Golfieri, Rita ^a   Patti, Corrado ^a   Fanti, Stefano ^a   Franchi, Roberto ^a   Lodi, Filippo ^a   Boschi, Stefano ^a   Bernardi, Mauro ^a   Trevisani, Franco ^a,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c Dipartimento di Medicina Interna   (Italy)

Author keywords

Adenoma; C 11 acetate; Carcinoma; F 18 fluorodeoxyglucose; Focal nodular hyperplasia; Hepatocellular; Liver neoplasms; PET

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER METASTASIS; MALE; NODULAR HYPERPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

ACETATES; ADENOMA, LIVER CELL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARBON; CARBON ISOTOPES; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOCAL NODULAR HYPERPLASIA; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 70349748807     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181b53488     Document Type: Article

References (32)

1. Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Dig Surg. 2002;19:109-113. (Pubitemid 34458055)
2. Cherqui D, Rahmouni A, Charlotte F, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology. 1995;22:1674-1681.
3. Hussain SM, van den Bos IC, Dwarkasing RS, et al. Hepatocellular adenoma: findings at state-of-the-art magnetic resonance imaging, ultrasound, computed tomography and pathologic analysis. Eur Radiol. 2006;16:1873-1886.
4. Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43:515-524.
5. Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol. 2005;39:401-412. (Pubitemid 40548078)
6. Herman P, Pugliese V, Machado MA, et al. Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment. World J Surg. 2000;24:372-376. (Pubitemid 30117769)
7. Pagani JJ. Biopsy of focal hepatic lesions. Comparison of 18 and 22 gauge needles. Radiology. 1983;147:673-675.
8. Bioulac-Sage P, Balabaud C, Bedossa P, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol. 2007;46:521-527. (Pubitemid 46201719)
9. Schiepers C, Hoh CK. Positron emission tomography as a diagnostic tool in oncology. Eur Radiol. 1998;8:1481-1494. (Pubitemid 128662821)
10. Oyama N, Akino H, Kanamauru H, et al. C-11 acetate PET imaging of prostate cancer. J Nucl Med. 2002;43:181-186. (Pubitemid 34151040)
11. Ho CL, Yu SC, Yeung DW. C-11 acetate PET imaging in hepatocellular carcinoma and other liver masses. J Nucl Med. 2003;44:213-221
12. Kurtaran A, Becherer A, Pfeffel F, et al. 18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liver. Liver. 2000;20:487-490. (Pubitemid 32000742)
13. Shiomi S, Kurooka H, Iwata Y, et al. Two cases of focal nodular hyperplasia of the liver: value of scintigraphy with Tc-99m GSA and positron emission tomography with FDG. Ann Nucl Med. 1999;13:427-431. (Pubitemid 30073614)
14. Patel PM, Alibazoglu H, Ali A, et al. False-positive uptake of FDG in a hepatic adenoma. Clin Nucl Med. 1997;22:490-491. (Pubitemid 28069022)
15. Giusti S, Donati F, Paolicchi A, et al. Hepatocellular adenoma: imaging findings and pathological correlation. Dig Liver Dis. 2005;37:200-205. (Pubitemid 41070540)
16. Golli M, Mathieu D, Anglade MC, et al. Focal nodular hyperplasia of the liver: value of color Doppler US in association with MR imaging. Radiology. 1993;187:113-117. (Pubitemid 23097869)
17. Bartolozzi C, Lencioni R, Paolicchi A, et al. Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography. Eur Radiol. 1997;7:1410-1415. (Pubitemid 127538376)
18. Dietrich CF, Schuessler G, Trojan J, et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol. 2005;78:704-707. (Pubitemid 41122683)
19. Bartolotta TV, Midiri M, Galia M, et al. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US. Abdom Imaging. 2007;32:84-91. (Pubitemid 46742682)
20. Hussain SM, Terkivatan T, Zondervan PE, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathological analysis. Radiographics. 2004;24:3-19. (Pubitemid 38134587)
21. Winterer JT, Kotter E, Ghanem N, et al. Detection and characterization of benign focal liver lesions with multislice CT. Eur Radiol. 2006;16:2427-2443. (Pubitemid 44649692)
22. Carlson SK, Johnson CD, Bendere CE, et al. CT of focal nodular hyperplasia of the liver. AJR Am J Roentgenol. 2000;174:705-712.
23. Asbach P, Klessen C, Koch M, et al. Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver. Clin Imaging. 2007;31:244-252. (Pubitemid 46962278)
24. Paulson EK, McClellan JS, Washington K, et al. Hepatic adenoma: MR characteristics and correlation with pathologic findings. Am J Roentgenol. 1994;163:113-116. (Pubitemid 24225698)
25. Paradis V, Laurent A, Flejou JF, et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology. 1997;26:891-895. (Pubitemid 27413654)
26. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48: 163-170. (Pubitemid 350199576)
27. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology. 1985;5:1194-1200. (Pubitemid 16222291)
28. Gharib AM, Thomasson D, Li KC. Molecular imaging of hepatocellular carcinoma. Gastroenterology. 2004;127:S153-S158.
29. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008;47:97-104. (Pubitemid 351171046)
30. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology. 2008;134:1682-1698.
31. Iozzo P, Geisler F, Oikonen V, et al. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET study. J Nucl Med. 2003;44:682-689. (Pubitemid 39655201)
32. Leclercq IA, Da Silva Morais A, Schroven B, et al. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanism and consequences. J Hepatol. 2007;47:142-156. (Pubitemid 46830723)